If other types of antibodies are raised, does that mean the virus is reactivated, or simply that the immune system is pumping out more antibodies?
Edit. I think Jonathan's post has just answered this.
Charles S writes
I think we have to be careful here. My feeling is that for most long-Covid patients the mechanism(s) driving this activity-induced fatigue is probably not going to be the same as that/those in ME/CFS; the former seems to be associated with damage and impairment of the...
Two responses to the Miller, Garner, and White Guardian letter, one from Charles Shepherd.
https://www.theguardian.com/society/2021/mar/14/when-rest-may-be-best-for-post-viral-fatigue
Yes, I agree with everything you've said. Looking for patterns is absolutely natural. In fact as humans we often see patterns that aren't there.
And the point about obsessing over symptoms — (i) i think there is (recent?) evidence this is no more significant in ME/CFS than other illnesses or in...
I'm not denying anyones symptoms, so I'm sorry if it came across that way. I am simply acknowledging that this phenomenon exists. If you've found what you think is a causal link between something and your symptom severity, then that's great. Paul Garner thinks he has found a causal link between...
Actually, I do recognise something similar. Especially from patient groups on FB! Some patients can be way too fast to attribute their symptom fluctuations to all sorts - something they ate, something they did, mouldy wall, changes in the weather, new supplement, etc. They can get really worked...
What I found most interesting about the letter was the suggestion that GET should be rolled out in long-Covid clinics before any clinical trial could test its efficacy. That seems wrong to me.
The key here is the argument that the *trials* don't show evidence of harms. I think we all know many reasons why they might not, but this needs to be communicated properly by someone who knows about this stuff.
We usually have people on hard. @Robert 1973 is always very good with letters. I'd do it myself but I don't know the trials inside out. The elephant in the room is that the patient experience / surveys are completely disparate with the trial findings as far as efficacy and 'harm'.
Yeah. They're all six months old, but I don't expect them to change anytime soon. It is my understanding that these have been revised with the draft guidelines in mind.
Just to expand a bit; some of us in the CMRC PAG are keen to work with BACME to really drill home the message that they have to change. I think Nina Muirhead has been in conversation with them, possibly with regards to medical education.
Now is the right time to be having these conversations...
I think it's good that Chris Ponting and Sonya Chowdhury are presenting. Clearly BACME still hasn't got the message. I will see if we can make progress on this through the CMRC Patient Advisory Group, as we have contact with Chris and Sonya.
I don't think boycotting is the right approach.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.